INDIAN BENCHMARK earsed its early losses and are trading higher on fresh buying by fund and retail investors in oil, metal and financials despite weakness in the global markets.
FURTHER, Aurobindo Pharma and Cipla will be in focus after the Medicines Patent Pool announced new sub-licensing agreements to improve access to novel investigational medicine tenofir alafenamide for HIV treatment. Adani Enterprises will be in focus on reports that the Australian government has approved the Carmichael Mine rail plan.
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Thursay while the DIIs were net buyers of Rs. 818cr, as per the provisional figures released by the NSE.
Get free trading in equity tips, free equity tips, stock tips, stock cash tips, stock futures tips, commodity tips, nifty tips, nifty futures, mcx tips, ncdex tips, and share market tips etc.
FURTHER, Aurobindo Pharma and Cipla will be in focus after the Medicines Patent Pool announced new sub-licensing agreements to improve access to novel investigational medicine tenofir alafenamide for HIV treatment. Adani Enterprises will be in focus on reports that the Australian government has approved the Carmichael Mine rail plan.
Trend in FII flows: The FIIs were net buyers of Rs 192cr in the cash segment on Thursay while the DIIs were net buyers of Rs. 818cr, as per the provisional figures released by the NSE.
Get free trading in equity tips, free equity tips, stock tips, stock cash tips, stock futures tips, commodity tips, nifty tips, nifty futures, mcx tips, ncdex tips, and share market tips etc.
No comments:
Post a Comment